817 |
Impact of Ischemic vs. Bleeding Endpoints: Lessons from ACUITY and HORIZONS |
Roxana Mehran |
Jul. 21. 09 |
816 |
European Consensus for Bifurcation PCI |
Thierry Lefevre |
Jul. 21. 09 |
815 |
Very Long-Term Outcomes of Left Main DES |
Alaide Chieffo |
Jul. 21. 09 |
814 |
Lessons from the CACTUS Trial |
Alaide Chieffo |
Jul. 21. 09 |
813 |
HORIZONS AMI: A Large Prospective Randomized Trial of PES vs. BMS in Patients with STEMI |
Gregg W. Stone |
Jul. 21. 09 |
812 |
Perspectives on the Use of Fondaparinux in ACS: Transitioning to the Cath Lab |
Ron Waksman |
Jul. 21. 09 |
811 |
Acute Myocardial Infarction - Expanding the Therapeutic Paradigm |
Howard A. Cohen |
Jul. 21. 09 |
810 |
MULTI-STRATEGY: Tirofiban vs. Abciximab During Primary PCI in STEMI |
Marco Valgimigli |
Jul. 21. 09 |
809 |
ON-TIME-2: Early Administration of Tirofiban During Primary PCI in STEMI |
Harry Suryapranata |
Jul. 21. 09 |
808 |
Thrombectomy in AMI- Perspectives on a Hot Topic |
On Topaz |
Jul. 21. 09 |